ORASURE TECHNOLOGIES, INC Line of Credit Facility, Interest Rate During Period
ORASURE TECHNOLOGIES, INC (OSUR) reported Line of Credit Facility, Interest Rate During Period of 4.15% for the 12-month period ending 2012-12-31, per its 10-K filed 2014-03-14.
Discontinued › Notes › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2014-03-14
- ORASURE TECHNOLOGIES, INC line of credit facility, interest rate during period for fiscal 2012 was 4.15%.
| Period end | Line of Credit Facility, Interest Rate During Period 6 month | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|---|
| 2012-12-31 | 4.15% 10-K · filed 2014-03-14 | |
| 2012-06-30 | 4.15% 10-Q · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |